Industry Trend

Site Sections


Menu













© 2023. All Rights reserved.

Overview for SANOFI

All Data per March 2, 2023

Industry:

Drug Manufacturers—General

Last Close:

89.18 EUR

Expected Dividend:

4.03 %

Payoffs per Year:

1.0
Business Summary

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antibodies; products for multiple sclerosis, neurology, other inflammatory diseases, immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes; and cardiovascular and established prescription products. It also supplies poliomyelitis, pertussis, and hib pediatric vaccines; and influenza, adult booster, meningitis, and travel and endemic vaccines. In addition, the company offers allergy, cough and cold, pain, digestive, and nutritional products; and other products, such as daily body lotions, anti-itch products, moisturizing and soothing lotions, and body and foot creams, as well as powders for eczema. It also has various pharmaceutical products and vaccines in development stage. Sanofi has collaboration agreement with GlaxoSmithKline to develop a recombinant Covid-19 vaccine; and a research collaboration with Stanford University School of Medicine to advance the understanding of immunology and inflammation through open scientific exchange. It also has a collaboration with TrialSpark Inc. to execute clinical research studies in the areas of chronic obstructive pulmonary disease. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France.


Competitors View

Ordering

ABBVIE

USA
1.03 4.28%
3.61%
7.39% 5.46% 1.0 4.36
-9.47%
43.02 13.08% 10.52 1.0

CHUGAI PHARMACEUTICAL

JPN
0.96 2.56%
0.0%
22.5% 6.68% 1.0 4.24
-32.13%
32.9 15.38% 77.21 2.0

PFIZER

USA
0.95 3.64%
3.96%
2.76% 3.76% 1.0 3.02
-11.11%
49.05 9.25% 42.54 3.0

ASTRAZENECA

GBR
1.04 4.07%
2.74%
1.15% 3.92% 1.0 11.56
-3.86%
98.3 11.66% 37.27 4.0

DAIICHI SANKYO

JPN
1.05 4.24%
0.0%
0.0% 3.88% 1.0 8.15
-17.26%
35.15 18.52% 61.0 5.0

SANOFI

FRA
1.01 3.78%
4.03%
0.74% 3.58% 1.0 0.57
-12.18%
51.83 7.75% 57.12 6.0

BRISTOL-MYERS SQUIBB

USA
0.98 2.8%
3.1%
1.83% 2.78% 1.0 0.5
-24.44%
34.92 17.8% 32.88 7.0

MERCK & CO.

USA
1.12 3.12%
2.64%
2.24% 3.15% 1.0 2.31
-11.68%
55.47 10.37% 36.13 8.0

KYOWA HAKKO KOGYO

JPN
0.96 1.88%
1.67%
7.74% 2.44% 1.0 3.6
-15.61%
35.6 3.07% 79.96 9.0

GILEAD SCIENCES

USA
1.16 2.74%
3.6%
5.91% 3.26% 1.0 0.15
-42.43%
33.49 -1.11% 31.01 10.0

ELI LILLY AND COMPANY

USA
1.04 2.43%
1.22%
2.86% 2.52% 1.0 7.52
-12.71%
42.91 5.87% 18.4 11.0

ROCHE

CHE
0.92 3.28%
3.51%
0.79% 3.11% 1.0 1.4
-15.85%
37.23 2.14% 26.53 12.0

AMGEN

USA
1.0 2.42%
3.28%
8.46% 3.24% 1.0 3.5
-9.93%
35.72 -5.0% 10.95 13.0

GLAXOSMITHKLINE

GBR
0.96 5.37%
5.27%
0.35% 5.0% -0.5 0.21
-24.56%
49.96 2.63% 19.03 14.0

ASTELLAS PHARMA

JPN
0.96 2.43%
0.0%
1.74% 2.4% 1.0 1.09
-19.06%
27.18 -1.76% 60.96 15.0

OTSUKA HOLDINGS CO., LTD.

JPN
0.93 2.21%
2.54%
0.0% 2.02% 1.0 -0.41
-14.62%
28.52 12.2% 71.29 16.0

BAYER

GER
1.02 2.51%
3.99%
4.7% 2.83% 0.5 -0.36
-58.76%
36.97 -17.89% 27.46 17.0

JOHNSON & JOHNSON

USA
0.98 2.68%
0.0%
0.0% 2.46% 1.0 -1.0
13.03%
44.08 2.58% 40.67 18.0

GRIFOLS SA

ESP
0.98 1.5%
nan%
4.84% 1.7% -0.5 0.24
-46.29%
31.86 -1.95% 31.7 nan


Information for SANOFI

Yield Triangle

Dividend & Close

Close Dividend Return (%)
Year
2012 70.73 2.65 3.75
2013 77.12 2.77 3.59
2014 75.66 2.80 3.70
2015 79.71 2.85 3.58
2016 76.90 2.93 3.81
2017 71.85 2.96 4.12
2018 75.66 3.03 4.00
2019 89.62 3.07 3.43
2020 78.70 3.15 4.00
2021 88.58 3.20 3.61
2023 89.18 3.59 4.03

Fundamentals

Chart